Ethics of HIV cure research: an unfinished agenda
Karine Dubé(University of North Carolina at Chapel Hill), Jeremy Sugarman(Johns Hopkins Berman Institute of Bioethics), Samuel Ndukwe(University of North Carolina at Chapel Hill), Jeff Taylor(University of North Carolina at Chapel Hill), Brandon Brown(University of California, Riverside), Lynda Dee(AIDS United), Michael Louella(Seattle University), John Kanazawa(University of North Carolina at Chapel Hill), John A. Sauceda(San Francisco AIDS Foundation), Christopher Roebuck(Philadelphia University), David Palm(University of North Carolina at Chapel Hill), Laney Henley(University of North Carolina at Chapel Hill), Jan Kosmyna(AIDS Clinical Trials Group), Parya Saberi(University of California, San Francisco), Hursch Patel(University of North Carolina at Chapel Hill), Mallory O. Johnson(California Coast University), Nora L. Jones(University of Pennsylvania), Morénike Giwa Onaiwu(Advisory Board Company (United States)), Laurie Sylla(Ministerio de Defensa), David Kelly(AIDS Clinical Trials Group), Danielle Campbell(Delaney AIDS Research Enterprise), Orbit Clanton(AIDS Clinical Trials Group)
Cited by 47
Related Papers
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|847
Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021
|Nature Medicine|2021|367
Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus–Infected Donors to Noninfected Recipients
|Annals of Internal Medicine|2018|295
Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting
|The Lancet HIV|2019|206
Team Structure and Culture Are Associated With Lower Burnout in Primary Care
|The Journal of the American Board of Family Medicine|2014|202